Convergence of Nanotechnology and Cardiovascular Medicine

Advances in the emergence of biological probes, materials, and analytical tools limited to the nanoscale size range, collectively referred to as ‘nanotechnology’, are increasingly being applied to the understanding and treatment of the major pathophysiological problems in cardiovascular medicine

Nicole Iverson

2009

Scholarcy highlights

  • Advances in the emergence of biological probes, materials, and analytical tools limited to the nanoscale size range, collectively referred to as ‘nanotechnology’, are increasingly being applied to the understanding and treatment of the major pathophysiological problems in cardiovascular medicine
  • Analytical techniques based on high-resolution microscopy and molecular-level fluorescence excitation processes capable of detecting nanoscale interactions have been used to elucidate cardiovascular pathology
  • Nanotechnology has significantly impacted diagnostic intervention in cardiology, with the use of nanoparticles as contrast agents, for targeted biomedical imaging of vulnerable plaques, for detection of specific pathologic targets signaling the onset of atherosclerosis, and for tracking inflammatory events
  • Arterioscler Thromb Vasc Biol 2002; 22: 1712–9 PubMed Article CAS Google Scholar

Need more features? Save interactive summary cards to your Scholarcy Library.